The new proton therapy system at Siteman Cancer Center is scheduled to open to patients in early 2020.
Uptick in Global Adoption
The proton therapy market continues to grow based the segment of modern, economically responsible, compact systems which Mevion invented. The new MEVION S250i™ system continues to be the system of choice for leading cancer centers. Two more hospitals are targeting openings for HYPERSCAN systems in late 2018 and a new system was just recently announced in Utah.
Ad Statistics
Times Displayed: 1943
Times Visited: 9 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
More information about the MEVION S250i system with HYPERSCAN Pencil Beam Scanning will be available at the Mevion booth 2844 at the 2018 Annual American Society for Radiation Oncology (ASTRO) meeting in San Antonio, Texas from Sunday October 21st through 23rd. Come learn why Mevion is the leader in compact proton therapy and see demonstrations of the economic feasibility, new proton room planning, as well as HYPERSCAN treatment planning demonstrations performed in conjunction with RaySearch Labs.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with presence in Europe and China. For more information, please visit www.mevion.com.
Back to HCB News
